Compare $CMB.AX vs $NEUP | Chartloom

Compare

$CMB.AX vs $NEUP

CMB.AX

Error

NEUP

Neuphoria Therapeutics Inc

Compare $CMB.AX vs $NEUP

CMB.AX

Error

NEUPNeuphoria Therapeutics Inc

CMB.AX

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

NEUPNeuphoria Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.5%

YTD performance

-12.0%

52W performance

-81.7%

FCF yield

-68.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMB.AX

NEUP

Not enough overlapping price history for this window.

Detailed metrics comparison

CMB.AX

NEUP

Neuphoria Therapeutics Inc

Market Cap

CMB.AX

NEUP$18M

Enterprise Value

CMB.AX

NEUP$-2M

Price

CMB.AX

NEUP$3.36

P/E Ratio

CMB.AX

NEUPN/A

P/S Ratio

CMB.AX

NEUP15.45x

EV/Sales

CMB.AX

NEUP-1.44x

EV/EBITDA

CMB.AX

NEUP0.00x

P/B Ratio

CMB.AX

NEUP0.76x

P/FCF Ratio

CMB.AX

NEUPN/A

EV/FCF

CMB.AX

NEUP0.14x

PEG Ratio

CMB.AX

NEUPN/A

Forward P/E (NTM)

CMB.AX

NEUPN/A

Forward P/S (NTM)

CMB.AX

NEUPN/A

Revenue (TTM)

CMB.AX

NEUP$1M

Revenue Growth (YoY)

CMB.AX

NEUP-92.5%

Forward Rev Growth

CMB.AX

NEUP0.0%

Gross Margin (TTM)

CMB.AX

NEUP0.0%

Operating Margin (TTM)

CMB.AX

NEUP0.0%

EBITDA Margin (TTM)

CMB.AX

NEUP-779.0%

Net Margin (TTM)

CMB.AX

NEUP-1145.6%

FCF Margin (TTM)

CMB.AX

NEUP-1052.0%

Net Income (TTM)

CMB.AX

NEUP$-13M

FCF (TTM)

CMB.AX

NEUP$-12M

EPS (TTM)

CMB.AX

NEUP-$2.49

ROE (TTM)

CMB.AX

NEUP-5591.0%

ROA (TTM)

CMB.AX

NEUP-4222.0%

ROIC (TTM)

CMB.AX

NEUP-5583.0%

Cash

CMB.AX

NEUP$20M

Debt

CMB.AX

NEUP$34K

Net Cash/Debt

CMB.AX

NEUP$20M

Current Ratio (TTM)

CMB.AX

NEUP27.85x

Quick Ratio (TTM)

CMB.AX

NEUP27.33x

Debt/Equity (TTM)

CMB.AX

NEUP0.00x

Debt/Assets (TTM)

CMB.AX

NEUP0.0%

Interest Coverage (TTM)

CMB.AX

NEUPN/A

Net Debt/EBITDA (TTM)

CMB.AX

NEUP0.00x

Beta

CMB.AX

NEUP0.76

52W Performance

CMB.AX

NEUP-81.7%

YTD Performance

CMB.AX

NEUP-12.0%

% from 52W High

CMB.AX

NEUP-82.5%

% from 52W Low

CMB.AX

NEUP5.3%

Asset Turnover (TTM)

CMB.AX

NEUP0.04x

FCF Yield (TTM)

CMB.AX

NEUP-68.1%

Earnings Yield (TTM)

CMB.AX

NEUP-74.1%

Dividend Yield (TTM)

CMB.AX

NEUPN/A

Rule of 40

CMB.AX

NEUP-1,144.5

EV/GP/RG

CMB.AX

NEUPN/A

Ticker research

View CMB.AX research View NEUP research

Metric	CMB.AX	NEUP Neuphoria Therapeutics Inc
Market & Valuation
Market Cap		$18M
Enterprise Value		$-2M
Price		$3.36
P/E Ratio		N/A
P/S Ratio		15.45x
EV/Sales		-1.44x
EV/EBITDA		0.00x
P/B Ratio		0.76x
P/FCF Ratio		N/A
EV/FCF		0.14x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$1M
Revenue Growth (YoY)		-92.5%
Forward Rev Growth		0.0%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-779.0%
Net Margin (TTM)		-1145.6%
FCF Margin (TTM)		-1052.0%
Net Income (TTM)		$-13M
FCF (TTM)		$-12M
EPS (TTM)		-$2.49
ROE (TTM)		-5591.0%
ROA (TTM)		-4222.0%
ROIC (TTM)		-5583.0%
Financial Health
Cash		$20M
Debt		$34K
Net Cash/Debt		$20M
Current Ratio (TTM)		27.85x
Quick Ratio (TTM)		27.33x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.76
52W Performance		-81.7%
YTD Performance		-12.0%
% from 52W High		-82.5%
% from 52W Low		5.3%
Efficiency & Yields
Asset Turnover (TTM)		0.04x
FCF Yield (TTM)		-68.1%
Earnings Yield (TTM)		-74.1%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-1,144.5
EV/GP/RG		N/A
Ticker research	View CMB.AX research	View NEUP research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

CMB.AX

NEUP

Neuphoria Therapeutics Inc

Market Cap

CMB.AX

NEUP$18M

Enterprise Value

CMB.AX

NEUP$-2M

Price

CMB.AX

NEUP$3.36

P/E Ratio

CMB.AX

NEUPN/A

P/S Ratio

CMB.AX

NEUP15.45x

EV/Sales

CMB.AX

NEUP-1.44x

EV/EBITDA

CMB.AX

NEUP0.00x

P/B Ratio

CMB.AX

NEUP0.76x

P/FCF Ratio

CMB.AX

NEUPN/A

EV/FCF

CMB.AX

NEUP0.14x

PEG Ratio

CMB.AX

NEUPN/A

Forward P/E (NTM)

CMB.AX

NEUPN/A

Forward P/S (NTM)

CMB.AX

NEUPN/A

Revenue (TTM)

CMB.AX

NEUP$1M

Revenue Growth (YoY)

CMB.AX

NEUP-92.5%

Forward Rev Growth

CMB.AX

NEUP0.0%

Gross Margin (TTM)

CMB.AX

NEUP0.0%

Operating Margin (TTM)

CMB.AX

NEUP0.0%

EBITDA Margin (TTM)

CMB.AX

NEUP-779.0%

Net Margin (TTM)

CMB.AX

NEUP-1145.6%

FCF Margin (TTM)

CMB.AX

NEUP-1052.0%

Net Income (TTM)

CMB.AX

NEUP$-13M

FCF (TTM)

CMB.AX

NEUP$-12M

EPS (TTM)

CMB.AX

NEUP-$2.49

ROE (TTM)

CMB.AX

NEUP-5591.0%

ROA (TTM)

CMB.AX

NEUP-4222.0%

ROIC (TTM)

CMB.AX

NEUP-5583.0%

Cash

CMB.AX

NEUP$20M

Debt

CMB.AX

NEUP$34K

Net Cash/Debt

CMB.AX

NEUP$20M

Current Ratio (TTM)

CMB.AX

NEUP27.85x

Quick Ratio (TTM)

CMB.AX

NEUP27.33x

Debt/Equity (TTM)

CMB.AX

NEUP0.00x

Debt/Assets (TTM)

CMB.AX

NEUP0.0%

Interest Coverage (TTM)

CMB.AX

NEUPN/A

Net Debt/EBITDA (TTM)

CMB.AX

NEUP0.00x

Beta

CMB.AX

NEUP0.76

52W Performance

CMB.AX

NEUP-81.7%

YTD Performance

CMB.AX

NEUP-12.0%

% from 52W High

CMB.AX

NEUP-82.5%

% from 52W Low

CMB.AX

NEUP5.3%

Asset Turnover (TTM)

CMB.AX

NEUP0.04x

FCF Yield (TTM)

CMB.AX

NEUP-68.1%

Earnings Yield (TTM)

CMB.AX

NEUP-74.1%

Dividend Yield (TTM)

CMB.AX

NEUPN/A

Rule of 40

CMB.AX

NEUP-1,144.5

EV/GP/RG

CMB.AX

NEUPN/A

Ticker research

View CMB.AX research View NEUP research

Metric	CMB.AX	NEUP Neuphoria Therapeutics Inc
Market & Valuation
Market Cap		$18M
Enterprise Value		$-2M
Price		$3.36
P/E Ratio		N/A
P/S Ratio		15.45x
EV/Sales		-1.44x
EV/EBITDA		0.00x
P/B Ratio		0.76x
P/FCF Ratio		N/A
EV/FCF		0.14x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$1M
Revenue Growth (YoY)		-92.5%
Forward Rev Growth		0.0%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-779.0%
Net Margin (TTM)		-1145.6%
FCF Margin (TTM)		-1052.0%
Net Income (TTM)		$-13M
FCF (TTM)		$-12M
EPS (TTM)		-$2.49
ROE (TTM)		-5591.0%
ROA (TTM)		-4222.0%
ROIC (TTM)		-5583.0%
Financial Health
Cash		$20M
Debt		$34K
Net Cash/Debt		$20M
Current Ratio (TTM)		27.85x
Quick Ratio (TTM)		27.33x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.76
52W Performance		-81.7%
YTD Performance		-12.0%
% from 52W High		-82.5%
% from 52W Low		5.3%
Efficiency & Yields
Asset Turnover (TTM)		0.04x
FCF Yield (TTM)		-68.1%
Earnings Yield (TTM)		-74.1%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-1,144.5
EV/GP/RG		N/A
Ticker research	View CMB.AX research	View NEUP research